EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neutralizing Antibodies: Role in Immune Response and Viral Vector Based Gene Therapy

Tatiana S Tsaregorodtseva, Aigul A Gubaidullina, Beata R Kayumova, Alisa A Shaimardanova, Shaza S Issa iD, Valeriya V Solovyeva iD, Albert A Sufianov, Galina Z Sufianova, Albert A Rizvanov iD

International Journal of Molecular Sciences · 29.05.2025 · 26 (11) · 5224

DOI: 10.3390/ijms26115224 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.05.2025. Verfasst von Tatiana S Tsaregorodtseva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia. Hauptthemen laut MEDLINE: Genetic Therapy, Genetic Vectors, Antibodies, Neutralizing. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation, Kazan Federal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutralizing antibodies (nAbs) are an important component of the immune system, which plays a dual role in modern medicine. On the one hand, they significantly limit the effectiveness of gene therapy based on viral vectors, reducing the effectiveness of treatment of diseases such as spinal muscular atrophy, which is especially evident with repeated administration of therapeutic vectors. On the other hand, nAbs is a promising tool for combating viral infections. This review systematizes current data on the mechanisms of nAbs formation against AAV vectors, analyzes the factors influencing their production, and discusses strategies to overcome this limitation, including modification of vectors and the development of methods to suppress the immune response. Special attention is paid to the prospects of using nAbs as therapeutic agents against viral infections. The key problems and possible directions of research development in this area are considered, which is important for improving approaches to the treatment of both rare genetic and infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyGenetic VectorsAntibodies, NeutralizingHumansAnimalsDependovirusVirus Diseases

Stichwörter der Autor:innen

antibodiesgene therapyhumoral immunityimmune responseimmunogenicity of vectorsneutralizing antibodiesovercoming the immune responsetolerance to gene therapyviral vectors

Substanzen

Antibodies, Neutralizing

Autor:innen und Institutionen

  • Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
  • Department of Genetics and Biotechnology, St. Petersburg State University, 199034 St. Petersburg, Russia.
  • Department of Neurosurgery, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia.
  • The Research and Educational Institute of Neurosurgery, Peoples' Friendship University of Russia (RUDN), 117198 Moscow, Russia.
  • Department of Pharmacology, Tyumen State Medical University, 625023 Tyumen, Russia.
  • Division of Medical and Biological Sciences, Tatarstan Academy of Sciences, 420111 Kazan, Russia.

ORCID-Profile: Shaza S Issa, Valeriya V Solovyeva, Albert A Rizvanov

Förderung

  • Ministry of Science and Higher Education of the Russian Federation
  • Kazan Federal University

Zitieren

APA

Tsaregorodtseva, T. S., Gubaidullina, A. A., Kayumova, B. R., Shaimardanova, A. A., Issa, S. S., Solovyeva, V. V., Sufianov, A. A., Sufianova, G. Z., & Rizvanov, A. A. (2025). Neutralizing Antibodies: Role in Immune Response and Viral Vector Based Gene Therapy. International Journal of Molecular Sciences, 26(11), 5224. https://doi.org/10.3390/ijms26115224

Vancouver

Tsaregorodtseva TS, Gubaidullina AA, Kayumova BR, Shaimardanova AA, Issa SS, Solovyeva VV, et al. Neutralizing Antibodies: Role in Immune Response and Viral Vector Based Gene Therapy. International Journal of Molecular Sciences. 2025;26(11):5224. doi:10.3390/ijms26115224

BibTeX
@article{Tsaregorodtseva2025,
  author = {Tsaregorodtseva, Tatiana S and Gubaidullina, Aigul A and Kayumova, Beata R and Shaimardanova, Alisa A and Issa, Shaza S and Solovyeva, Valeriya V and Sufianov, Albert A and Sufianova, Galina Z and Rizvanov, Albert A},
  title = {Neutralizing Antibodies: Role in Immune Response and Viral Vector Based Gene Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {11},
  pages = {5224},
  doi = {10.3390/ijms26115224}
}
Kostenlos starten →